RegisterLogin

Fucoxanthin

CAT: 0804-HY-N2302-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-N2302-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Fucoxanthin (all-trans-Fucoxanthin) is a marine carotenoid and shows anti-obesity, anti-diabetic, anti-oxidant, anti-inflammatory and anticancer activities[1][2][3][4][5][6][7][8][9].
CAS Number
[3351-86-8]
Product Name Alternative
All-trans-Fucoxanthin
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial; Caspase; c-Myc; ERK; NO Synthase; PPAR
Type
Natural Products
Related Pathways
Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Stem Cell/Wnt; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Fucoxanthin.html
Concentration
10mM
Purity
99.38
Solubility
DMSO : 12.5 mg/mL (ultrasonic)
Smiles
O=C(/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C([H])=[C@@]=C([C@@]1(O)C)C(C)(C[C@H](OC(C)=O)C1)C)C[C@]2(C3(C)C)[C@@](C)(C[C@@H](O)C3)O2
Molecular Formula
C42H58O6
Molecular Weight
658.91
Precautions
H302, H315, H319, H335
References & Citations
[1]Gammone MA, et al. Anti-obesity activity of the marine carotenoid fucoxanthin. Mar Drugs. 2015 Apr 13;13 (4) :2196-214.|[2]Méresse S, Fodil M, Fleury F, Chénais B. Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: A Promising Bioactive Compound for Cancer Therapy. Int J Mol Sci. 2020;21 (23) :9273. |[3]Yoshimi Niwano, et al. In Vivo and in Vitro Toxicity Studies of Fucoxanthin, a Marine Carotenoid. null. 2011;0 (0) :319-328. |[4]Šudomová M, et al. A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases. Mar Drugs. 2019 Nov 14;17 (11) :641.|[5]Ye G, et al. Fucoxanthin may inhibit cervical cancer cell proliferation via downregulation of HIST1H3D. J Int Med Res. 2020 Oct;48 (10) :300060520964011. |[6]Okuzumi J, et al. Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells. Cancer Lett. 1990 Nov 19;55 (1) :75-81. |[7]Ishikawa C, et al. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Int J Cancer. 2008 Dec 1;123 (11) :2702-12. |[8]Shiratori K, et al. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp Eye Res. 2005 Oct;81 (4) :422-8. |[9]Yang H, et al. Role of Fucoxanthin towards Cadmium-induced renal impairment with the antioxidant and anti-lipid peroxide activities. Bioengineered. 2021 Dec;12 (1) :7235-7247.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Natural Products
Clinical Information
Phase 2
Isoform
Caspase 3; Caspase 8; Caspase 9; ERK2; iNOS; PPARα; PPARγ

Related Products

CatalogName

Alternative Products

CatalogName
RM-F030800-01Fucoxanthin
A16976-10Fucoxanthin 10mg
A16976-50Fucoxanthin 50mg
A16976-1Fucoxanthin 1mg
A16976-100Fucoxanthin 100mg
A16976-2Fucoxanthin 2mg
A16976-25Fucoxanthin 25mg
A16976-5Fucoxanthin 5mg
A16976-500Fucoxanthin 500mg
A16976-10mM-DFucoxanthin 10mM * 1mL in DMSO

Popular Products